Alibaba to pay $600m to settle illegal drug sales allegations in US probe
Key takeaways
- E-commerce giant admitted it failed to prevent about 80,000 illegal drug product sales, according to US Justice Department.
- The Justice Department said on Wednesday that Alibaba and AUS Merchant Services agreed as part of the deal to accept responsibility for the acts of their officers and employees, and enhance their compliance programmes.
- Those transactions had a combined merchandise value of more than $200m, according to the Justice Department.
Why this matters: an international story with cross-border implications worth tracking.
E-commerce giant admitted it failed to prevent about 80,000 illegal drug product sales, according to US Justice Department.
xwhatsapp-strokecopylinkgoogle Add Al Jazeera on Googleinfo Alibaba employees raised concerns about whether illegal products were being sold [File: Mahesh Kumar A/AP]By AP and Reuters Published On 2 Jul 20262 Jul 2026Chinese technology and e-commerce giant Alibaba and its United States-based payment processor will pay $600m to resolve allegations that they failed to prevent illegal drug sales, according to the US Justice Department.
The Justice Department said on Wednesday that Alibaba and AUS Merchant Services agreed as part of the deal to accept responsibility for the acts of their officers and employees, and enhance their compliance programmes.